FindTrial
Sign In

The prevalence and molecular characterization of enterovirus and parechovirus infections in infants within the first three months of life

The prevalence and molecular characterization of enterovirus and parechovirus infections in infants within the first three months of life

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20230613008
Enrollment
150
Registered
2023-06-13
Start date
2023-06-19
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Newborns or infants in the first three months of life with sepsis like Infants, enterovirus, parechovirus, clinical manifestations

Interventions

The infants who have negative results for available investigations at the hospitals, will recruit in the study to investigate for enterovirus, parechovirus.
Diagnostic
Investigated for enterovirus and parechovirus

Sponsors

Chulabhorn Royal Academy
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 3 Months

Inclusion criteria

Inclusion criteria: Infants in the first 3 months of life with fever and /or sepsis-like symptoms

Exclusion criteria

Exclusion criteria: No consent received

Design outcomes

Primary

MeasureTime frame
Incidence of enterovirus during the study period numbers of cases or percent,Investigation for Parechovirus During the study period Numbers of cases and percents—

Secondary

MeasureTime frame
N/A N/A N/A—

Countries

Thailand

Contacts

Public ContactNanthida Phattraprayoon

Chulabhorn Royal Academy

nanthida.pha@cra.ac.th0886247388

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026